ADVFN Logo ADVFN

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,667.56
0.08%
Dow Jones
41,985.35
0.08%
US Dollar vs MXN
20.2389
0.48%
Brent Oil
71.775
-0.13%
Bitcoin
84,363.47
0.28%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Terns Pharmaceuticals Inc (TERN)

  7. Terns Pharmaceuticals Inc (TERN) Noticias

TERN

Terns Pharmaceuticals (TERN)

Terns Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:TERN
FechaHoraFuenteTítuloSímboloCompañía
20/03/202515:36Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TERNTerns Pharmaceuticals Inc
20/03/202515:23Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:TERNTerns Pharmaceuticals Inc
20/03/202515:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TERNTerns Pharmaceuticals Inc
20/03/202515:05GlobeNewswire Inc.Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate UpdatesNASDAQ:TERNTerns Pharmaceuticals Inc
26/02/202515:05GlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
25/02/202507:05GlobeNewswire Inc.Terns Pharmaceuticals Provides Program Updates and Announces Participation at TD Cowen 45th Annual Healthcare ConferenceNASDAQ:TERNTerns Pharmaceuticals Inc
24/02/202515:05GlobeNewswire Inc.Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial OfficerNASDAQ:TERNTerns Pharmaceuticals Inc
20/02/202515:05GlobeNewswire Inc.Terns Pharmaceuticals Appoints Robert Azelby to Board of DirectorsNASDAQ:TERNTerns Pharmaceuticals Inc
05/02/202516:28Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:TERNTerns Pharmaceuticals Inc
05/02/202515:05GlobeNewswire Inc.Terns Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences ConferenceNASDAQ:TERNTerns Pharmaceuticals Inc
03/02/202518:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TERNTerns Pharmaceuticals Inc
03/02/202515:05GlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
08/01/202515:05GlobeNewswire Inc.Terns Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:TERNTerns Pharmaceuticals Inc
03/12/202406:00GlobeNewswire Inc.Terns Pharmaceuticals Announces Positive Early Data from Phase 1 CARDINAL Trial of TERN-701 for Chronic Myeloid LeukemiaNASDAQ:TERNTerns Pharmaceuticals Inc
18/11/202415:05GlobeNewswire Inc.Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of DirectorsNASDAQ:TERNTerns Pharmaceuticals Inc
12/11/202415:45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TERNTerns Pharmaceuticals Inc
12/11/202415:05GlobeNewswire Inc.Terns Pharmaceuticals Reports Third Quarter 2024 Financial Results and Corporate UpdatesNASDAQ:TERNTerns Pharmaceuticals Inc
06/11/202415:05GlobeNewswire Inc.Terns Pharmaceuticals to Participate in Upcoming November Investor ConferencesNASDAQ:TERNTerns Pharmaceuticals Inc
24/10/202413:02Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:TERNTerns Pharmaceuticals Inc
12/09/202418:00GlobeNewswire Inc.Terns Announces Closing of Public Offering of Shares of Common Stock and Pre-Funded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:TERNTerns Pharmaceuticals Inc
11/09/202415:09Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TERNTerns Pharmaceuticals Inc
10/09/202421:50GlobeNewswire Inc.Terns Announces Pricing of Upsized $150.15 Million Public OfferingNASDAQ:TERNTerns Pharmaceuticals Inc
09/09/202415:01GlobeNewswire Inc.Terns Announces Proposed Public OfferingNASDAQ:TERNTerns Pharmaceuticals Inc
09/09/202406:05GlobeNewswire Inc.Terns Pharmaceuticals Announces Positive Phase 1 Clinical Trial Results with TERN-601 Once-Daily Oral GLP-1R Agonist for the Treatment of ObesityNASDAQ:TERNTerns Pharmaceuticals Inc
05/08/202415:05GlobeNewswire Inc.Terns Pharmaceuticals Reports Second Quarter 2024 Financial Results and Corporate UpdatesNASDAQ:TERNTerns Pharmaceuticals Inc
29/07/202415:05GlobeNewswire Inc.Terns Pharmaceuticals Appoints Biotech Executive Elona Kogan as Chief Legal Officer and Announces Upcoming CFO TransitionNASDAQ:TERNTerns Pharmaceuticals Inc
21/06/202417:30GlobeNewswire Inc.Terns Pharmaceuticals Highlights New Preclinical Data Supporting TERN-501 in Combination with a GLP-1R Agonist for Obesity at the ADA’s 84th Annual Scientific Sessions and Upcoming Conference ParticipationNASDAQ:TERNTerns Pharmaceuticals Inc
03/06/202415:10GlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
30/05/202407:05GlobeNewswire Inc.Terns Pharmaceuticals to Participate in Upcoming June Investor ConferencesNASDAQ:TERNTerns Pharmaceuticals Inc
17/05/202415:05GlobeNewswire Inc.Terns Pharmaceuticals to Participate in UBS Obesity Therapeutics DayNASDAQ:TERNTerns Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:TERN

Su Consulta Reciente

USI
USTECH100
US Tech 100
PM
XAUUSD
Gold vs US Dollar
CCOM
US30
US 30
USOTC
RHHBY
Roche (QX)
COIN
BTCUSD
Bitcoin
NASDAQ
TSLA
Tesla
COIN
XRPUSD
Ripple
NASDAQ
NVDA
NVIDIA
NYSE
CVX
Chevron
FX
EURMXN
Euro vs MXN
COIN
DOGEUSD
Dogecoin
AMEX
SPY
SPDR S&P 500
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
AAPL
Apple
USOTC
ADDYY
Adidas (QX)
Delayed Upgrade Clock
ADVFN Logo
México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios